ASAjeet Pratap Singh

Ajeet Pratap Singh

*This is an algorithmically generated author record based on publicly available information.

Ajeet Pratap Singh has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genomic discovery of EF-24 targets unveils antitumorigenic mechanisms in leukemia cells

    by Ajeet P. Singh, Noah Wax, James Duncan, Ana S. Fernandes, Jonathan L. Jacobs

    Curcumin, a polyphenolic compound derived from the plant Curcuma longa L., has demonstrated a wide range of therapeutic properties, including potential anticancer effects. However, its clinical efficacy is limited due to poor bioavailability and stability. To overcome these challenges, curcumin analogs like EF-24 have been developed with improved pharmacological properties. In this study, in order to improve our understanding of EF-24’s potential mechanisms of action, we used whole-transcriptome sequencing to identify genome-wide functional impacts of EF-24 treatment in leukemia cells. These results enabled the development of a testable model system for associating druggable genes with clinical disease targets related to EF-24 treatment. To develop our model of the transcriptional response to EF-24 treatment, we used four well studied model cell lines for leukemia research, specifically the chronic myeloid leukemia (CML) cell line K-562 and acute myeloid leukemia (AML) cell lines HL-60, Kasumi-1, and THP-1. Cell viability was significantly decreased in all four of these leukemia models following EF-24 treatment as compared to untreated controls. We discovered that the genes ATF3, CLU, HSPA6, OSGIN1, ZFAND2A, and CXCL8, which are associated with reduced cell viability and proliferation, were consistently upregulated in all EF-24–treated cell lines. Further analysis of the tested cell lines revealed the activation of various signaling pathways, but notably the S100 family signaling pathway was consistently activated in all four cell lines. Our results provide critical insights into the molecular underpinnings of EF-24’s antitumor efficacy against leukemia subtypes, highlighting its multifaceted impact on signaling pathways and gene networks that regulate cell survival, proliferation, and immune responses in cell line models of myeloid leukemia subtypes.


  • Open Access

    Genomic Discovery of EF-24 Targets Unveils Antitumorigenic Mechanisms in Leukemia Cells

    by Ajeet P. Singh, Noah Wax, James Duncan, Ana Fernandes, Jonathan L. Jacobs

    Curcumin, a polyphenolic compound derived from the plant Curcuma longa L., has demonstrated a wide range of therapeutic properties, including potential anticancer effects. However, its clinical efficacy is limited due to poor bioavailability and stability. To overcome these challenges, curcumin analogs like EF-24 have been developed with improved pharmacological properties. In this study, we used whole-transcriptome profiling to identify the genome-wide functional impacts of EF-24 treatment in leukemia cells to improve our understanding of its potential mechanisms of action. This approach allowed us to establish a model system for associating druggable genes with clinical disease targets. We used the chronic myeloid leukemia (CML) cell line K-562 and acute myeloid leukemia (AML) cell lines HL-60, Kasumi-1, and THP-1 to conduct EF-24 treatment studies. Cell viability was significantly decreased in the EF-24–treated cells as compared to the untreated controls. We discovered that the genes ATF3, CLU, HSPA6, OSGIN1, ZFAND2A, and CXCL8, which are associated with reduced cell viability and proliferation, were consistently upregulated in all EF-24–treated cell lines. Further analysis of the tested cell lines revealed the activation of various signaling pathways, including the STAT1 regulated S100 family signaling pathway, that controlled downstream gene expression in response to EF-24 treatment. Our results elucidate the molecular mechanisms underlying EF-24’s antitumor efficacy against leukemia, highlighting its multifaceted impact on signaling pathways and gene networks that regulate cell survival, proliferation, and immune responses in myeloid leukemia cells. Significance: This study reveals how EF-24, a curcumin analog, disrupts key signaling pathways in chronic and acute myeloid leukemia cell lines, offering insights to enhance targeted therapies and provide new targets for investigation. Conflict of Interest Statement: The authors declare no potential conflicts of interest.

  • Open Access

    1351 Unusual differential for generalised weakness in a 10 month child

    by Ajeet Pratap Singh, Hugh Johnson, Neha Khanna

    Background A ten month old girl was referred to the Emergency department by her primary care physician with complaints of progressive generalised weakness. Parents started noticing significant weakness in both lower limbs with painful cries when pulled to sit and during nappy changes. She was born by IVF pregnancy at 32 weeks gestation and had an uneventful neonatal course. There were no concerns with regards to development and at age of ten months, she was able to Crawl/weight bear/stand prior to these new onset symptoms. When examined, she was lying supine on a flat bed with noticeably reduced lower limb movements. Detailed neurological evaluation confirmed bilateral lower limb lower motor neuron type flaccid paralysis and absent reflexes. In view of rapid deterioration, Guillain Barre syndrome and transverse myelitis were the top differential diagnosis as she had no obvious sources or signs of infection. The child underwent necessary bloods and imaging of brain and spine as an inpatient. MRI spine revealed a solid extradural mass at level of L1– L3 reported as suspected nerve sheath tumour, likely shwannoma. She was transferred to a tertiary oncology unit where a diagnosis of adrenal neuroblastoma with spinal extension/compression was made in conjunction after biopsy and repeat MRI reports. Background Neuroblastoma is the most common solid extradural tumor in children with 40% of the cases diagnosed under the age of one year. The adrenal gland is the most common primary site, followed by abdominal, thoracic, cervical and pelvic sympathetic ganglia. Primary tumours, usually in the retro peritoneum are able to invade the spinal canal through the neural foramina, creating a so-called ‘dumbbell’ tumor . The subsequent epidural spinal cord compression, an oncologic emergency, can cause pain, motor or sensory deficits, or loss of bowel and/or bladder control. The subtle and gradual onset of such neurologic symptoms in young children can make diagnosis difficult. Objectives Not Required ( case report ) Methods Not Required ( case report ) Results Not Required ( case report ) Conclusions Learning/conclusion : Although not a very rare presentation for retroperitoneal (adrenal) neuroblastoma, but this was definitely a surprising and unexpected finding for a child presenting with predominantly lower limb weakness. On reflection, it could have been disastrous for the child and the family if left unnoticed or misdiagnosed. Every child should have a complete examination irrespective of presentation or magnitude of illness or complaint. All necessary imaging should be performed prior to more invasive investigations.

  • Open Access

    A coordinated function of lncRNA HOTTIP and miRNA-196b underpinning leukemogenesis by targeting Fas signaling

    by Ajeet P. Singh, Huacheng Luo, Meghana Matur, Melanie Eshelman, Arati Sharma, Suming Huang

    MicroRNAs (miRNAs) may modulate more than 60% of human coding genes and act as negative regulators, while long non-coding RNAs (lncRNAs) regulate gene expression on multiple levels by interacting with chromatin, functional proteins, and RNAs such as mRNAs and microRNAs. However, the crosstalk between lncRNA HOTTIP and miRNAs in leukemogenesis remains elusive. Using combined integrated analyses of global miRNA expression profiling and state-of-the-art genomic analyses of chromatin such as ChIRP-seq., (genome wide HOTTIP binding analysis), ChIP-seq., and ATAC-seq., we found that miRNA genes are directly controlled by HOTTIP. Specifically, the HOX cluster miRNAs (miR-196a, miR-196b, miR-10a and miR-10b), located cis & trans , were most dramatically regulated and significantly decreased in HOTTIP -/- AML cells. HOTTIP bound to the miR-196b promoter, and HOTTIP deletion reduced chromatin accessibility and enrichment of active histone modifications at HOX cluster associated miRNAs in AML cells, while reactivation of HOTTIP restored miR gene expression and chromatin accessibility in the CTCF-boundary-attenuated AML cells. Inactivation of HOTTIP or miR-196b promotes apoptosis by altering the chromatin signature at the FAS promoter and increasing FAS expression. Transplantation of miR-196b knockdown MOLM13 cells in NSG mice increased overall survival compared to wild-type cells. Thus, HOTTIP remodels the chromatin architecture around miRNAs to promote their transcription, consequently repressing tumor suppressors and promoting leukemogenesis.

  • Open Access

    Single Cell Analysis Reveals Multi-faceted miR-375 Regulation of the Intestinal Crypt

    by Michael T. Shanahan, Matt Kanke, Ajeet P. Singh, Jonathan W. Villanueva, Adrian J. McNairn, Oyebola O. Oyesola, Alessandro Bonfini, Yu-Han Hung, Breanna Sheahan, Jordana C. Bloom, et al.

    Summary: The role of individual miRNAs in small intestinal (SI) epithelial homeostasis is under-explored. In this study, we discovered that miR-375 is among the most enriched miRNAs in intestinal crypts and stem cells (ISCs), especially facultative ISCs. We then showed by multiple manipulations, including CRISPR/Cas9 editing, that miR-375 is strongly suppressed by Wnt-signaling. Single-cell RNA-seq analysis of SI crypt-enriched cells from miR-375 knockout (375-KO) mice revealed elevated numbers of tuft cells and increased expression of pro-proliferative genes in ISCs. Accordingly, the genetic loss of miR-375 promoted resistance to helminth infection and enhanced the regenerative response to irradiation. The conserved effects of miR-375 were confirmed by gain-of-function studies in Drosophila midgut stem cells in vivo. Moreover, functional experiments in enteroids uncovered a regulatory relationship between miR-375 and Yap1 that controls cell survival. Finally, analysis of mouse model and clinical data revealed an inverse association between miR-375 levels and intestinal tumor development. Highlights: miR-375 is one of the most enriched miRNAs in ISCs, especially facultative ISCs. miR-375 modifies tuft cell abundance and pro-proliferative gene expression in ISCs. Loss of miR-375 in mice enhances the host response to helminth infection and crypt regeneration. Mouse and human intestinal cancer are associated with reduced miR-375 expression. eTOC Blurb: Sethupathy and colleagues show that miR-375 is a Wnt-responsive, ISC-enriched miRNA that serves as a break on intestinal crypt proliferation. They also show that miR-375 modulates tuft cell abundance and pro-proliferative gene expression in ISCs, that miR-375 loss enhances the host response to helminth infection as well as crypt regeneration post-irradiation, and its reduced expression is associated with intestinal cancer.


  • The core SWI/SNF catalytic subunit Brg1 regulates nephron progenitor cell proliferation and differentiation

    by Jeannine M. Basta, Ajeet P. Singh, Lynn Robbins, Lisa Stout, Michelle Pherson, Michael Rauchman


  • Open Access

    A role for BRG1 in the regulation of genes required for development of the lymphatic system

    by Ajeet Pratap Singh, Julie Foley, Arpit Tandon, Dhiral Phadke, H. Karimi Kinyamu, Trevor K. Archer

    A role for BRG1 in the regulation of genes required for development of the lymphatic system A role for BRG1 in the regulation of genes required for development of the lymphatic system


  • Open Access

    Gut Microbial Influences on the Mammalian Intestinal Stem Cell Niche

    by Bailey C. E. Peck, Michael T. Shanahan, Ajeet P. Singh, Praveen Sethupathy

    The mammalian intestinal epithelial stem cell (IESC) niche is comprised of diverse epithelial, immune, and stromal cells, which together respond to environmental changes within the lumen and exert coordinated regulation of IESC behavior. There is growing appreciation for the role of the gut microbiota in modulating intestinal proliferation and differentiation, as well as other aspects of intestinal physiology. In this review, we evaluate the diverse roles of known niche cells in responding to gut microbiota and supporting IESCs. Furthermore, we discuss the potential mechanisms by which microbiota may exert their influence on niche cells and possibly on IESCs directly. Finally, we present an overview of the benefits and limitations of available tools to study niche-microbe interactions and provide our recommendations regarding their use and standardization. The study of host-microbe interactions in the gut is a rapidly growing field, and the IESC niche is at the forefront of host-microbe activity to control nutrient absorption, endocrine signaling, energy homeostasis, immune response, and systemic health.


  • Open Access

    Brg1 Enables Rapid Growth of the Early Embryo by Suppressing Genes That Regulate Apoptosis and Cell Growth Arrest

    by Ajeet P. Singh, Julie F. Foley, Mark Rubino, Michael C. Boyle, Arpit Tandon, Ruchir Shah, Trevor K. Archer

    SWI/SNF (switching/sucrose nonfermenting)-dependent chromatin remodeling establishes coordinated gene expression programs during development, yet important functional details remain to be elucidated. We show that the Brg1 (Brahma-related gene 1; Smarca4) ATPase is globally expressed at high levels during postimplantation development and its conditional ablation, beginning at gastrulation, results in increased apoptosis, growth retardation, and, ultimately, embryonic death. Global gene expression analysis revealed that genes upregulated in Rosa26CreERT2; Brg1flox/flox embryos (here referred to as Brg1d/d embryos to describe embryos with deletion of the Brg1flox/flox alleles) negatively regulate cell cycle progression and cell growth. In addition, the p53 (Trp53) protein, which is virtually undetectable in early wild-type embryos, accumulated in the Brg1d/d embryos and activated the p53-dependent pathways. Using P19 cells, we show that Brg1 and CHD4 (chromodomain helicase DNA binding protein 4) coordinate to control target gene expression. Both proteins physically interact and show a substantial overlap of binding sites at chromatin-accessible regions adjacent to genes differentially expressed in the Brg1d/d embryos. Specifically, Brg1 deficiency results in reduced levels of the repressive histone H3 lysine K27 trimethylation (H3K27me3) histone mark and an increase in the amount of open chromatin at the regulatory region of the p53 and p21 (Cdkn1a) genes. These results provide insights into the mechanisms by which Brg1 functions, which is in part via the p53 program, to constrain gene expression and facilitate rapid embryonic growth.


  • Open Access

    Analysis of the SWI/SNF chromatin-remodeling complex during early heart development and BAF250a repression cardiac gene transcription during P19 cell differentiation

    by Ajeet Pratap Singh, Trevor K. Archer

    The regulatory networks of differentiation programs and the molecular mechanisms of lineage-specific gene regulation in mammalian embryos remain only partially defined. We document differential expression and temporal switching of BRG1-associated factor (BAF) subunits, core pluripotency factors and cardiac-specific genes during post-implantation development and subsequent early organogenesis. Using affinity purification of BRG1 ATPase coupled to mass spectrometry, we characterized the cardiac-enriched remodeling complexes present in E8.5 mouse embryos. The relative abundance and combinatorial assembly of the BAF subunits provides functional specificity to Switch/Sucrose NonFermentable (SWI/SNF) complexes resulting in a unique gene expression profile in the developing heart. Remarkably, the specific depletion of the BAF250a subunit demonstrated differential effects on cardiac-specific gene expression and resulted in arrhythmic contracting cardiomyocytes in vitro. Indeed, the BAF250a physically interacts and functionally cooperates with Nucleosome Remodeling and Histone Deacetylase (NURD) complex subunits to repressively regulate chromatin structure of the cardiac genes by switching open and poised chromatin marks associated with active and repressed gene expression. Finally, BAF250a expression modulates BRG1 occupancy at the loci of cardiac genes regulatory regions in P19 cell differentiation. These findings reveal specialized and novel cardiac-enriched SWI/SNF chromatin-remodeling complexes, which are required for heart formation and critical for cardiac gene expression regulation at the early stages of heart development.